Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1982 May;36(2):730–736. doi: 10.1128/iai.36.2.730-736.1982

Ocular Albumin Fluorophotometric Quantitation of Endotoxin-Induced Vascular Permeability

Scott W Cousins 1, James T Rosenbaum 2, Robert B Guss 1, Peter R Egbert 1
PMCID: PMC351291  PMID: 6806194

Abstract

Bacterial endotoxin (lipopolysaccharide; LPS) is known to alter systemic vascular permeability, but this effect is difficult to monitor and quantitate in vivo. The ocular vessels of the rabbit are particularly sensitive to LPS. Using a slit lamp equipped with a fluorophotometer, we have adapted a method to quantitate endotoxin-induced ocular vascular permeability by measuring the accumulation of fluorescein isothiocyanate-conjugated albumin into the anterior chamber of the eye. After intravenous administration of Salmonella typhimurim LPS, the anterior chamber fluorescence and blood fluorescence were measured at intervals of 15 min and 1 h, respectively, over 4 h. In controls, maximal fluorescence in the anterior chamber was 3.1 ± 0.8% of blood fluorescence. Doses of LPS as low as 0.25 μg/kg produced an ocular/serum fluorescence ratio of 17.6 ± 4.9. A dose of 2.5 μg of LPS per kg tended to produce a higher ratio (68.0 ± 7.1) than a larger dose of 50 μg/kg (30.5 ± 16.6). Permeability changes began within 30 min after LPS, and the rate of dye accumulation varied over time, with maximal leakage usually occurring 90 min after LPS, but occasionally occurring much later. Repeated doses produced tolerance. By conjugating albumin to rhodamine and utilizing a second filter with the slit lamp to measure accumulation of this dye, we demonstrated the persistence of marked permeability during a period when intraocular fluorescein isothiocyanate and albumin levels were relatively constant. This methodology indicates that extremely low doses of LPS induce ocular permeability changes and that neither the time course nor the dose response of this effect is linear. Ocular fluorophotometry is a sensitive, noninvasive technique to study the dynamics and pharmacology of LPS-induced permeability changes.

Full text

PDF
730

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AUST J. B., JOHNSON J. A., VISSCHER M. B. Plasma sequestration in endotoxin shock. Surg Forum. 1957;8:8–10. [PubMed] [Google Scholar]
  2. BILL A. THE DRAINAGE OF ALBUMIN FROM THE UVEA. Exp Eye Res. 1964 Jun;3:179–187. doi: 10.1016/s0014-4835(64)80033-6. [DOI] [PubMed] [Google Scholar]
  3. Bengtsson E. The effect of imidazole on the disruption of the blood-aqueous barrier in the rabbit eye. Invest Ophthalmol. 1976 Apr;15(4):315–320. [PubMed] [Google Scholar]
  4. Brigham K. L., Bowers R. E., McKeen C. R. Methylprednisolone prevention of increased lung vascular permeability following endotoxemia in sheep. J Clin Invest. 1981 Apr;67(4):1103–1110. doi: 10.1172/JCI110123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CHIEN S., SINCLAIR D. G., DELLENBACK R. J., CHANG C., PERIC B., USAMI S., GREGERSEN M. I. EFFECT OF ENDOTOXIN ON CAPILLARY PERMEABILITY TO MACROMOLECULES. Am J Physiol. 1964 Sep;207:518–522. doi: 10.1152/ajplegacy.1964.207.3.518. [DOI] [PubMed] [Google Scholar]
  6. Christy J. H. Pathophysiology of gram-negative shock. Am Heart J. 1971 May;81(5):694–701. doi: 10.1016/0002-8703(71)90014-7. [DOI] [PubMed] [Google Scholar]
  7. Dyster-Aas H. K., Fritz H., Krakau C. E. Quantitation of endotoxin-induced protein increase in the aqueous humor of the rabbit's eye. Acta Pathol Microbiol Scand. 1969;77(4):739–749. doi: 10.1111/j.1699-0463.1969.tb04516.x. [DOI] [PubMed] [Google Scholar]
  8. ECKMAN P. L., KING W. M., BRUNSON J. G. Studies on the blood brain barrier. I. Effects produced by a single injection of gramnegative endotoxin on the permeability of the cerebral vessels. Am J Pathol. 1958 Jul-Aug;34(4):631–643. [PMC free article] [PubMed] [Google Scholar]
  9. Eakins K. E. Prostaglandin and non-prostaglandin mediated breeakdown of the blood-aqueous barrier. Exp Eye Res. 1977;25 (Suppl):483–498. doi: 10.1016/s0014-4835(77)80043-2. [DOI] [PubMed] [Google Scholar]
  10. Fletcher J. R., Ramwell P. W. E. coli endotoxin shock in the baboon: treatment with lidocaine or indomethacin. Adv Prostaglandin Thromboxane Res. 1978;3:183–192. [PubMed] [Google Scholar]
  11. Flynn J. T. Endotoxic shock in the rabbit: the effects of prostaglandin and arachidonic acid administration. J Pharmacol Exp Ther. 1978 Sep;206(3):555–566. [PubMed] [Google Scholar]
  12. GILBERT R. P. Effect of antihistaminic and antiserotonin drugs on vascular responses to E. coli endotoxin in the cat. Proc Soc Exp Biol Med. 1959 Feb;100(2):346–349. doi: 10.3181/00379727-100-24622. [DOI] [PubMed] [Google Scholar]
  13. GORDON P., LIPTON M. A. Hormonal modification of endotoxin mortality in mice. Proc Soc Exp Biol Med. 1960 Oct;105:162–164. doi: 10.3181/00379727-105-26045. [DOI] [PubMed] [Google Scholar]
  14. Hadler N. M. A pathogenetic model for erosive synovitis: lessons from animal arthritides. Arthritis Rheum. 1976 Mar-Apr;19(2):256–266. doi: 10.1002/art.1780190222. [DOI] [PubMed] [Google Scholar]
  15. Howes E. L., Jr, Aronson S. B., McKay D. G. Ocular vascular permeability. Effect of systemic administration of bacterial endotoxin. Arch Ophthalmol. 1970 Sep;84(3):360–367. doi: 10.1001/archopht.1970.00990040362017. [DOI] [PubMed] [Google Scholar]
  16. Howes E. L., Jr, McKay D. G. Comparison of the ocular effects of circulating endotoxin and immune complexes: role of vasoactive amines. J Immunol. 1975 Feb;114(2 Pt 2):734–737. [PubMed] [Google Scholar]
  17. JANOFF A., WEISSMANN G., ZWEIOFACH B. W., THOMAS L. Pathogenesis of experimental shock. IV. Studies on lysosomes in normal and tolerant animals subjected to lethal trauma and endotoxemia. J Exp Med. 1962 Oct 1;116:451–466. doi: 10.1084/jem.116.4.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MACLEAN L. D., SPINK W. W., VISSCHER M. B., WEIL M. H. Canine intestinal and liver weight changes induced by E. coli endotoxin. Proc Soc Exp Biol Med. 1956 Jul;92(3):602–605. doi: 10.3181/00379727-92-22557. [DOI] [PubMed] [Google Scholar]
  19. Milner K. C. Patterns of tolerance to endotoxin. J Infect Dis. 1973 Jul;128(Suppl):237–245. doi: 10.1093/infdis/128.supplement_1.s237. [DOI] [PubMed] [Google Scholar]
  20. Morrison D. C., Ulevitch R. J. The effects of bacterial endotoxins on host mediation systems. A review. Am J Pathol. 1978 Nov;93(2):526–618. [PMC free article] [PubMed] [Google Scholar]
  21. Okada M., Shimada K. The continuous and quantitative observation of permeability changes of the blood-aqueous barrier in allergic inflammation of the eye. Invest Ophthalmol Vis Sci. 1980 Feb;19(2):169–175. [PubMed] [Google Scholar]
  22. Robin E. D., Carey L. C., Grenvik A., Glauser F., Gaudio R. Capillary leak syndrome with pulmonary edema. Arch Intern Med. 1972 Jul;130(1):66–71. [PubMed] [Google Scholar]
  23. Rosenbaum J. T. Why HLA-B27: an analysis based on two animal models. Ann Intern Med. 1981 Feb;94(2):261–263. doi: 10.7326/0003-4819-94-2-261. [DOI] [PubMed] [Google Scholar]
  24. Shine K. I., Kuhn M., Young L. S., Tillisch J. H. Aspects of the management of shock. Ann Intern Med. 1980 Nov;93(5):723–734. doi: 10.7326/0003-4819-93-5-723. [DOI] [PubMed] [Google Scholar]
  25. Simon G., Bertók L., Morava E., Winter M. The effect of E. coli endotoxins upon the fluorescein permeability of the blood-aqueous humour barrier. Med Pharmacol Exp Int J Exp Med. 1967;16(2):147–151. doi: 10.1159/000136980. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES